Calidi Biotherapeutics Inc. Featured in NetworkNewsWire Spotlight on Genetic Medicines for Cancer...
Calidi Biotherapeutics Inc. (NYSE American: CLDI), a clinical-stage biotech company, has been featured in a NetworkNewsWire editorial titled ‘Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers.’ The article sheds light...